title: Interventional cardiology live case presentations: regulatory considerations.
authors.affiliation: Office of Device Evaluation, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA. andrew.farb@fda.hhs.gov
authors.forename: Andrew
authors.initials: A
authors.lastname: Farb
authors.forename: Sheila A
authors.initials: SA
authors.lastname: Brown
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Wolf
authors.forename: Bram
authors.initials: B
authors.lastname: Zuckerman
mesh_terms: D002309:Cardiology / Q000331:legislation & jurisprudence* / Q000592:standards*; D018795:Device Approval / Q000331:legislation & jurisprudence* / Q000592:standards*; D006801:Humans; D019114:Remote Consultation / Q000331:legislation & jurisprudence / Q000592:standards*; D035703:Therapies, Investigational / Q000592:standards; D014481:United States